26 Analgesic drugs Flashcards
26.01 OPIOID DRUGS
Opioid agonists: morphine, diamorphine (heroin), buprenorphine, codeine, oxycodone - actions
analgesia
sedation
euphoria/reduced anxiety
physical/psychological dependence
cough suppression and respiratory depression
inhibition of gut motility
26.01 OPIOID DRUGS
Opioid agonists: morphine, diamorphine (heroin), buprenorphine, codeine, oxycodone - MOA
activates µ opioid receptors in the brain and spinal cord to inhibit pain transmission and modify the central perception of pain
activation of κ receptors may exert an additional effect on pain transmission in the spinal cord
may inhibit the activation of sensory nerve endings
opioid receptors are G protein–coupled receptors, which inhibit adenylate cyclase activity, open K+ channels and inhibit the opening of Ca2+ channels in nerve endings
26.01 OPIOID DRUGS
Opioid agonists: morphine, diamorphine (heroin), buprenorphine, codeine, oxycodone - abs/distrib/elim
given orally or by SC/IM injection
glucuronic acid conjugation in the liver
half-lives: morphine 3-4h, buprenorphine 12h
the actions of diamorphine and codeine are due, at least in part, to metabolism to morphine
26.01 OPIOID DRUGS
Opioid agonists: morphine, diamorphine (heroin), buprenorphine, codeine, oxycodone - clinical use
moderate to severe chronic and postoperative pain (codeine for mild pain)
epidural anaesthesia
neuropathic pain
treatment of painful cough
diarrhoea
26.01 OPIOID DRUGS
Opioid agonists: morphine, diamorphine (heroin), buprenorphine, codeine, oxycodone - adverse effects
hypotension
constipation, nausea, vomiting, drowsiness, dizziness tolerance, dependence and withdrawal effects
larger doses - coma with respiratory depression
26.01 OPIOID DRUGS
Opioid agonists: morphine, diamorphine (heroin), buprenorphine, codeine, oxycodone - special notes
naloxone is an opioid receptor antagonist at µ, δ and κ receptors and given in opioid overdoses
can cause withdrawal symptoms in opioid addicts
26.02 OPIOID DRUGS
Synthetic analogues: pethidine, fentanyl, remifentanil, sufentanil - actions
analgesia
euphoria
physical/psychological dependence
respiratory depression
inhibition of gut motility
(antimuscarinic effects of pethidine cause tachycardia)
26.02 OPIOID DRUGS
Synthetic analogues: pethidine, fentanyl, remifentanil, sufentanil - MOA
activates µ opioid receptors in the brain and spinal cord to inhibit pain transmission
activation of κ receptors may exert an additional effect on pain transmission in the spinal cord
may inhibit the activation of sensory nerve endings
26.02 OPIOID DRUGS
Synthetic analogues: pethidine, fentanyl, remifentanil, sufentanil - abs/distrib/elim
given orally or IM
pethidine is subject to hydrolysis and P450 oxidation, half-life 3-5h
fentanyl is also available as a transdermal patch for long-term effects
remifentanil has a very short half-life (0.1h)
26.02 OPIOID DRUGS
Synthetic analogues: pethidine, fentanyl, remifentanil, sufentanil - clinical use
moderate to severe pain
pethidine does not reduce uterine contractions so favoured for labour pain
remifentanil and sufentanil are given IV for surgical analgesia
26.02 OPIOID DRUGS
Synthetic analogues: pethidine, fentanyl, remifentanil, sufentanil - adverse effects
constipation (less than morphine), nausea, vomiting, drowsiness, dizziness, tolerance, dependence and withdrawal effects
larger doses - coma with respiratory depression
26.03 OPIOID DRUGS
Long-acting µ opioid receptor agonist: methadone - actions
analgesia
euphoria
physical/psychological dependence
respiratory depression
inhibition of gut motility
26.03 OPIOID DRUGS
Long-acting µ opioid receptor agonist: methadone - MOA
activates µ opioid receptors in the brain and spinal cord to inhibit pain transmission and modify the central perception of pain
may inhibit the activation of sensory nerve endings
26.03 OPIOID DRUGS
Long-acting µ opioid receptor agonist: methadone - abs/distrib/elim
oral absorption
long duration of action
P450 metabolism in liver
half-life 15-40h
26.03 OPIOID DRUGS
Long-acting µ opioid receptor agonist: methadone - clinical use
analgesia
maintenance of opioid addicts and assistance in withdrawal program
26.03 OPIOID DRUGS
Long-acting µ opioid receptor agonist: methadone - adverse effects
constipation, nausea, vomiting, drowsiness, dizziness
tolerance, dependence and withdrawal effects
larger doses - coma with respiratory depression and possible cardiac dysrhythmia